Esophagitis after administration of the 1273-RNAm SARS-CoV-2 vaccine

Velilla Moliner, Joaquín; Garcia Palacio, Jessica; Barberán Bernardos, Alba

doi:10.1016/j.medcle.2022.07.001

array:24 ["pii" => "S2387020622003047" "issn" => "23870206" "doi" => "10.1016/j.medcle.2022.07.001" "estado" => "S300" "fechaPublicacion" => "2022-07-22" "aid" => "5920" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;159:e13-e14" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S002577532200077X" "issn" => "00257753" "doi" => "10.1016/j.medcli.2022.01.018" "estado" => "S300" "fechaPublicacion" => "2022-07-22" "aid" => "5920" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;159:e13-e14" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "Carta al Editor" "titulo" => "Esofagitis aguda tras la administración de vacuna ARNm-1273 contra el SARS-COV-2" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e13" "paginaFinal" => "e14" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Esophagitis after administration of the 1273-RNAm SARS-CoV-2 vaccine" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 735 "Ancho" => 900 "Tamanyo" => 71858 ] ] "descripcion" => array:1 [ "es" => "Ulceraciones en esófago." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Joaquín Velilla Moliner, Jessica Garcia Palacio, Alba Barberán Bernardos" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Joaquín" "apellidos" => "Velilla Moliner" ] 1 => array:2 [ "nombre" => "Jessica" "apellidos" => "Garcia Palacio" ] 2 => array:2 [ "nombre" => "Alba" "apellidos" => "Barberán Bernardos" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020622003047" "doi" => "10.1016/j.medcle.2022.07.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622003047?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002577532200077X?idApp=UINPBA00004N" "url" => "/00257753/0000015900000002/v1_202207080542/S002577532200077X/v1_202207080542/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020622003096" "issn" => "23870206" "doi" => "10.1016/j.medcle.2022.01.014" "estado" => "S300" "fechaPublicacion" => "2022-07-22" "aid" => "5912" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Clin. 2022;159:106" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Image in medicine" "titulo" => "Colitis due to idelalisib in a patient with follicular lymphoma" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "106" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Colitis por idelalisib en un paciente con linfoma folicular" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1036 "Ancho" => 1508 "Tamanyo" => 96320 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "PET/CT with increased diffuse metabolic uptake of the descending colon and sigmoid colon compatible with colitis." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Marta Canelo-Vilaseca, Josep-Maria Ribera Santasusana, Juan-Manuel Sancho Cia" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Marta" "apellidos" => "Canelo-Vilaseca" ] 1 => array:2 [ "nombre" => "Josep-Maria" "apellidos" => "Ribera Santasusana" ] 2 => array:2 [ "nombre" => "Juan-Manuel" "apellidos" => "Sancho Cia" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775322000616" "doi" => "10.1016/j.medcli.2022.01.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775322000616?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622003096?idApp=UINPBA00004N" "url" => "/23870206/0000015900000002/v1_202207200641/S2387020622003096/v1_202207200641/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020622003175" "issn" => "23870206" "doi" => "10.1016/j.medcle.2022.02.016" "estado" => "S300" "fechaPublicacion" => "2022-07-22" "aid" => "5965" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2022;159:e12" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Reply" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "e12" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ana Piñar-Gutiérrez, Pablo Remón-Ruiz, Alfonso Soto-Moreno" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Ana" "apellidos" => "Piñar-Gutiérrez" ] 1 => array:2 [ "nombre" => "Pablo" "apellidos" => "Remón-Ruiz" ] 2 => array:2 [ "nombre" => "Alfonso" "apellidos" => "Soto-Moreno" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0025775322001737" "doi" => "10.1016/j.medcli.2022.02.026" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775322001737?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622003175?idApp=UINPBA00004N" "url" => "/23870206/0000015900000002/v1_202207200641/S2387020622003175/v1_202207200641/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Esophagitis after administration of the 1273-RNAm SARS-CoV-2 vaccine" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e13" "paginaFinal" => "e14" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Joaquín Velilla Moliner, Jessica Garcia Palacio, Alba Barberán Bernardos" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Joaquín" "apellidos" => "Velilla Moliner" "email" => array:1 [ 0 => "joaquinvelilla@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Jessica" "apellidos" => "Garcia Palacio" ] 2 => array:2 [ "nombre" => "Alba" "apellidos" => "Barberán Bernardos" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Urgencias, Hospital Miguel Servet de Zaragoza, Zaragoza, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Esofagitis aguda tras la administración de vacuna ARNm-1273 contra el SARS-COV-2" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 735 "Ancho" => 900 "Tamanyo" => 71858 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Esophageal ulcerations." ] ] ] "textoCompleto" => "Esophagitis is a group of clinical entities manifesting with inflammation and lesions in the esophageal mucosa. These conditions can be linked to multiple etiopathogenic mechanisms in addition to gastroesophageal reflux, with the most common ones being the consumption of certain medications, infectious agents, or involvement of the mucosa in the context of immunoallergic diseases.In this paper we describe the case of an immunocompetent patient presenting with symptoms of esophagitis two days after receiving the first dose of messenger ribonucleic vaccine (mRNA) mRNA-1273 (Moderna) against the 2019 coronavirus disease (COVID-19).This was a 20-year-old male patient with a history of recurrent episodes of streptococcal pharyngitis. As remarkable immunological history he reported rhinitis and allergic conjunctivitis since his childhood, a reaction to the pertussis vaccine (fever and irritability), and atopic dermatitis.He visited the Emergency Room due to experiencing dysphagia, odynophagia, and retrosternal pain for 5 days, but no associated heartburn. In addition, he had a fever of up to 39 °C and reported complete inability to ingest food orally. He had received the first dose of the cited vaccine two days prior to the onset of these symptoms.The blood work performed revealed normal findings and a COVID-19 detection polymerase chain reaction (PCR) test was negative.An urgent gastroscopy was consequently carried out, detecting multiple superficial, small, and punctiform ulcerations in the middle third of his esophagus suggestive of infectious esophagitis. Initial endoscopic diagnosis: infectious esophagitis of probable herpetic origin (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).<elsevierMultimedia ident="fig0005"></elsevierMultimedia>During his stay at the clinic, he had serology tests performed against human immunodeficiency viruses (HIV) 1 and 2, cytomegalovirus (CMV), and immunoglobulin G (IgG) of the herpes simplex virus (HSV), all of which were negative.A pathology study yielded a diagnosis of severe, acute, ulcerative esophagitis without viral cytopathic changes nor fungal structures permeating the epithelium. An immunohistochemistry study was also negative for HSV-1 and CMV. The examined sample was found to contain lymphocytes, neutrophils, and squamous cells that were either dispersed or forming small plaques, without overlapping nuclei nor cytologic atypia.During his stay at the clinic, the patient required total parenteral nutrition for 6 days, as well as intravenous antiviral therapy due to the initial suspected diagnosis of herpetic esophagitis, exhibiting a gradual clinical improvement until achieving the reintroduction of an oral diet. Given the above reaction, the patient refused to receive the second dose of the vaccine. In the absence of a clear cause of the esophagitis, the case was notified to the Spanish Pharmacovigilance System for Medicines for Human Use due to its potential relationship with the vaccination.Different authors have described the existence of a possible relationship between infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the onset of autoimmune conditions mediated by a mechanism of molecular mimicry and cross-reactivity.<a class="elsevierStyleCrossRef" href="#bib0005">1</a> These reactions might also be triggered by vaccination, particularly in genetically predisposed individuals.<a class="elsevierStyleCrossRef" href="#bib0010">2</a>Vaccine-associated autoimmunity is a well-known phenomenon attributed to cross-reactivity between antigens or to an effect of the adjuvant (substance that increases the immunogenicity of antigens).<a class="elsevierStyleCrossRef" href="#bib0015">3</a> With the appearance of the COVID-19 vaccine, this issue was further complicated by the nucleic acid formulation and the accelerated development process enforced by the emergency situation resulting from the pandemic.<a class="elsevierStyleCrossRef" href="#bib0020">4</a> Because mRNA vaccines have shown the highest level of evidence based on the efficacy and safety profiles observed in clinical trials, their use is currently both authorized and recommended.Thus far, mRNA vaccines were primarily designed for the treatment of cancer and infectious diseases. They are based on the synthesis of ribonucleic acid (RNA) strands encoding the desired antigenic proteins and take advantage of the intrinsic immunogenicity of nucleic acids.It is important to note that the regulation of these immune pathways is widely considered to be the basis of several immune-mediated diseases, especially in genetically predisposed subjects.In this particular case of a patient with a personal history of atopic dermatitis, allergic rhinitis, and a childhood vaccine reaction, we believe that the vaccine may have been the trigger of the manifested autoimmune reaction. The time elapsed between the administration of the first vaccine and the onset of the clinical picture in our patient yielded a score of 6 in the Naranjo causality algorithm (possible causal reaction)." "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "Please cite this article as: Moliner JV, Palacio JG, Bernardos AB. Esofagitis aguda tras la administración de vacuna ARNm-1273 contra el SARS-COV-2. Med Clin (Barc). 2022;159:e13–e14." ] ] "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 735 "Ancho" => 900 "Tamanyo" => 71858 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Esophageal ulcerations." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmunediseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Vojdani" 1 => "D. Kharrazian" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Clin Immunol" "fecha" => "2020" "volumen" => "217" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Talotta" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Clin Immunol" "fecha" => "2021" "volumen" => "224" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "From tolerance to autoimmunity: is there a risk in early life vaccination?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Goriely" 1 => "M. Goldman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Comp Pathol" "fecha" => "2007" "volumen" => "137" "paginaInicial" => "57" "paginaFinal" => "61" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.N. Kostoff" 1 => "D. Kanduc" 2 => "A.L. Porter" 3 => "Y. Shoenfeld" 4 => "D. Calina" 5 => "M.B. Briggs" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Toxicol Rep" "fecha" => "2020" "volumen" => "7" "paginaInicial" => "51" "paginaFinal" => "64" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000015900000002/v1_202207200641/S2387020622003047/v1_202207200641/en/main.assets" "Apartado" => array:4 [ "identificador" => "43309" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000015900000002/v1_202207200641/S2387020622003047/v1_202207200641/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020622003047?idApp=UINPBA00004N"]

ISSN: 2387-0206

Launched in 1943, Medicina Clínica is a fortnightly journal aimed at the promotion of clinical research and practice among internal medicine and other specialists. The key characteristics of Medicina Clínica are the scientific and methodological rigor of its manuscripts, the topicality of its contents, and, especially, its practical focus with highly useful information for clinical practice. Medicina Clínica is predominantly interested in publishing original research manuscripts, which are rigorously selected according to their quality, originality, and interest, and also in continued medical education-oriented manuscripts, which are commissioned by the journal to relevant authors (Editorials, Reviews, and Diagnosis and Treatment). These manuscripts contain updated topics with a major clinical or conceptual relevance in modern medicine. The journal adheres to the standards of academic research publications in all aspects including peer-review and ethical principles. Medicina Clínica is included in the General and Internal Medicine category of Thomson Reuters.

See more Open Access Option

Indexed in:

Current Contents/Clinical Medicine, Journal Citation Reports, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, MEDES, PASCAL, SCOPUS, SciVerse ScienceDirect

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.371

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.511

View more metrics

Journal Information

Previous article | Next article

Vol. 159. Issue 2.

Pages e13-e14 (July 2022)

Lee este artículo en Español

Export reference

Download PDF

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)

Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”

Subscribe to

Medicina Clínica (English Edition)

More information

Purchase

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now

Contact

Phone for subscriptions and reporting of errors

From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.

Calls from Spain

932 415 960

Calls from outside Spain

+34 932 415 960

E-mail

atencionalcliente@elsevier.com

Publish in

Medicina Clínica

Tools

Free access articles

Associations of physical activity, sedentary time,...

Med Clin. 2024;163:327-35

Burden of COVID-19 variant omicron in immunocompromised...

Med Clin. 2024;163:347-59

Raynaud phenomenon in a baseball...

Med Clin. 2024;163:e79

Medicina Clínica (English Edition) follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Article

Subscribe to our newsletter